IRIDEX (IRIX) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
25 Apr, 2026Voting matters and shareholder proposals
Election of five director nominees: Nick Chen, Beverly A. Huss, Patrick Mercer, William Moore, and Scott Shuda.
Ratification of BPM LLP as independent registered public accounting firm for fiscal year 2026 ending January 2, 2027.
Advisory vote to approve compensation of named executive officers.
Board of directors and corporate governance
Board recommends a vote FOR all director nominees and all proposals presented.
Executive compensation and say-on-pay
Advisory vote scheduled to approve the compensation of named executive officers.
Partial view of Summaries dataset, powered by Quartr API
Latest events from IRIDEX
- Operational efficiency and clinical innovation drive growth and recurring revenue expansion.IRIX
Planet MicroCap Las Vegas 202618 Jun 2026 - Innovative laser solutions and operational efficiencies drive growth and profitability in eye care.IRIXInvestor presentation4 Jun 2026
- Profitability achieved in Q4 2025, with strong growth in retina and glaucoma laser markets.IRIXLytham Partners Spring 2026 Investor Conference29 May 2026
- Q1 revenue stable at $11.8M; glaucoma growth offsets Retina headwinds; 2026 guidance reaffirmed.IRIXQ1 202619 May 2026
- Annual meeting covers director elections, auditor ratification, and executive pay advisory vote.IRIXProxy filing24 Apr 2026
- Strong 2025 revenue growth, first positive adjusted EBITDA, and positive cash flow outlook.IRIXQ4 202526 Mar 2026
- Q2 revenue was $12.6M, net loss narrowed, and liquidity improved with new funding.IRIXQ2 20242 Feb 2026
- Q3 revenue fell 10% year-over-year, but cost cuts and new reimbursement policies target Q4 breakeven.IRIXQ3 202414 Jan 2026
- Q4 revenue and margins improved, with strategic investment supporting a positive 2025 outlook.IRIXQ4 202424 Dec 2025